XPH Among Health Care ETFs
End-of-day Nov 19, 2026 · 39 Health care ETFs by 1W
| Returns | Today | 1W | 1M | 3M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| Total return | −1.3% | −5.4% | −0.8% | −12.8% | +13.6% | +22.2% | +81.4% | +32.7% | +72.1% | +412.7% |
| Peer average | −1.5% | −5.1% | −2.8% | −5.1% | +15.0% | +19.1% | +61.3% | +21.3% | +153.6% | — |
| S&P 500 · VOO | −2.0% | −5.5% | −7.4% | −6.3% | +5.8% | +9.7% | +65.8% | +65.5% | +290.0% | — |
$47 of every $1,000 in XPH is Xeris
| # | ||||||
|---|---|---|---|---|---|---|
| 1 | XERSXeris Biopharma | Healthcare | 4.68% | $467.77 | 1.4M | $23.7M |
| 2 | AMRXAmneal Pharmaceuticals | Healthcare | 2.69% | $269.25 | 624K | $13.7M |
| 3 | MANEVeradermics | Healthcare | 2.66% | $265.92 | 108K | $13.5M |
| 4 | LLYELI Lilly + | Healthcare | 2.61% | $261.08 | 9,578 | $13.2M |
| 5 | VTRSViatris | Healthcare | 2.61% | $260.90 | 653K | $13.2M |
| 6 | PRGOPerrigo | Healthcare | 2.51% | $250.76 | 751K | $12.7M |
| 7 | ZTSZoetis | Healthcare | 2.48% | $247.77 | 147K | $12.6M |
| 8 | ELANElanco Animal Health | Healthcare | 2.41% | $240.67 | 457K | $12.2M |
| 9 | RPRXRoyalty Pharma | Healthcare | 2.41% | $240.58 | 178K | $12.2M |
| 10 | MAZEMAZE Therapeutics | Healthcare | 2.40% | $239.74 | 390K | $12.2M |
| 11 | COLLCollegium Pharmaceutical | Healthcare | 2.30% | $230.12 | 450K | $11.7M |
| 12 | ETONETON Pharmaceuticals | Healthcare | 2.24% | $223.68 | 183K | $11.3M |
| 13 | PBHPrestige Consumer Healthcare | Healthcare | 2.21% | $220.64 | 221K | $11.2M |
| 14 | LGNDLigand Pharmaceuticals | Healthcare | 2.20% | $220.13 | 37K | $11.2M |
| 15 | JAZZJAZZ Pharmaceuticals | Healthcare | 2.18% | $217.96 | 45K | $11.1M |
of the $111B in 39 Health care ETFs
| # | Ticker | Company | Weight ▼ |
|---|---|---|---|
| 1 | XERS | Xeris Biopharma | 4.68% |
| 2 | AMRX | Amneal Pharmaceuticals | 2.69% |
| 3 | MANE | Veradermics | 2.66% |
| 4 | LLY | ELI Lilly + | 2.61% |
| 5 | VTRS | Viatris | 2.61% |
| 6 | PRGO | Perrigo | 2.51% |
| 7 | ZTS | Zoetis | 2.48% |
| 8 | ELAN | Elanco Animal Health | 2.41% |
| 9 | RPRX | Royalty Pharma | 2.41% |
| 10 | MAZE | MAZE Therapeutics | 2.40% |
Estimated yearly cost excludes trading costs and assumes constant assets.
| Ex-date | Paid | Per share |
|---|---|---|
| Sep 21, 2026 | Sep 23, 2026 | $0.0416 |
| Jun 22, 2026 | Jun 24, 2026 | $0.0590 |
| Mar 23, 2026 | Mar 25, 2026 | $0.0610 |
| Dec 22, 2025 | Dec 24, 2025 | $0.11 |
| Sep 22, 2025 | Sep 24, 2025 | $0.10 |
| Jun 23, 2025 | Jun 25, 2025 | $0.0959 |
| Mar 24, 2025 | Mar 26, 2025 | $0.15 |
| Dec 23, 2024 | Dec 26, 2024 | $0.15 |
| Sep 23, 2024 | Sep 25, 2024 | $0.19 |
| Jun 24, 2024 | Jun 26, 2024 | $0.16 |
| Mar 18, 2024 | Mar 21, 2024 | $0.17 |
| Dec 18, 2023 | Dec 21, 2023 | $0.17 |